CN108685987A - 一种中药组合物及其制备方法和应用 - Google Patents
一种中药组合物及其制备方法和应用 Download PDFInfo
- Publication number
- CN108685987A CN108685987A CN201810661699.4A CN201810661699A CN108685987A CN 108685987 A CN108685987 A CN 108685987A CN 201810661699 A CN201810661699 A CN 201810661699A CN 108685987 A CN108685987 A CN 108685987A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- medicine composition
- weight
- added
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 57
- 239000000203 mixture Substances 0.000 title claims abstract description 56
- 238000002360 preparation method Methods 0.000 title claims abstract description 18
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 claims abstract description 42
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 claims abstract description 21
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims abstract description 21
- 239000005844 Thymol Substances 0.000 claims abstract description 21
- 229940041616 menthol Drugs 0.000 claims abstract description 21
- 229960000790 thymol Drugs 0.000 claims abstract description 21
- 239000000419 plant extract Substances 0.000 claims abstract description 18
- 239000000022 bacteriostatic agent Substances 0.000 claims abstract description 12
- 230000008961 swelling Effects 0.000 claims abstract description 11
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 42
- 241000196324 Embryophyta Species 0.000 claims description 34
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 30
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 claims description 28
- 229940099352 cholate Drugs 0.000 claims description 27
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 26
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 22
- 235000019441 ethanol Nutrition 0.000 claims description 20
- 238000001914 filtration Methods 0.000 claims description 18
- 239000007788 liquid Substances 0.000 claims description 18
- 208000020670 canker sore Diseases 0.000 claims description 17
- 241000205585 Aquilegia canadensis Species 0.000 claims description 16
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 claims description 15
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 13
- 239000003795 chemical substances by application Substances 0.000 claims description 13
- 238000000605 extraction Methods 0.000 claims description 13
- 235000011187 glycerol Nutrition 0.000 claims description 13
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 13
- 239000003921 oil Substances 0.000 claims description 13
- 235000010447 xylitol Nutrition 0.000 claims description 13
- 239000000811 xylitol Substances 0.000 claims description 13
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 13
- 229960002675 xylitol Drugs 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 11
- 238000002156 mixing Methods 0.000 claims description 11
- 239000000341 volatile oil Substances 0.000 claims description 11
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 claims description 10
- 230000003196 chaotropic effect Effects 0.000 claims description 9
- 239000000706 filtrate Substances 0.000 claims description 9
- 238000010438 heat treatment Methods 0.000 claims description 9
- 238000004064 recycling Methods 0.000 claims description 9
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 8
- 229930006000 Sucrose Natural products 0.000 claims description 8
- 238000013461 design Methods 0.000 claims description 8
- 239000002904 solvent Substances 0.000 claims description 8
- 239000005720 sucrose Substances 0.000 claims description 8
- 239000010642 eucalyptus oil Substances 0.000 claims description 7
- 229940044949 eucalyptus oil Drugs 0.000 claims description 7
- 238000012856 packing Methods 0.000 claims description 7
- 241000287828 Gallus gallus Species 0.000 claims description 6
- 244000304222 Melaleuca cajuputi Species 0.000 claims description 6
- 235000001167 Melaleuca cajuputi Nutrition 0.000 claims description 6
- 102000016943 Muramidase Human genes 0.000 claims description 6
- 108010014251 Muramidase Proteins 0.000 claims description 6
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 claims description 6
- 229940079593 drug Drugs 0.000 claims description 6
- 229960000274 lysozyme Drugs 0.000 claims description 6
- 239000004325 lysozyme Substances 0.000 claims description 6
- 235000010335 lysozyme Nutrition 0.000 claims description 6
- 239000002244 precipitate Substances 0.000 claims description 6
- 239000007921 spray Substances 0.000 claims description 6
- 235000007516 Chrysanthemum Nutrition 0.000 claims description 5
- 244000189548 Chrysanthemum x morifolium Species 0.000 claims description 5
- 240000007594 Oryza sativa Species 0.000 claims description 5
- 235000007164 Oryza sativa Nutrition 0.000 claims description 5
- 241000191940 Staphylococcus Species 0.000 claims description 5
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 claims description 5
- -1 polyhexamethylene guanidine Polymers 0.000 claims description 5
- 229920000136 polysorbate Polymers 0.000 claims description 5
- 235000009566 rice Nutrition 0.000 claims description 5
- 229960004889 salicylic acid Drugs 0.000 claims description 5
- 235000019640 taste Nutrition 0.000 claims description 5
- WBWWGRHZICKQGZ-HZAMXZRMSA-N taurocholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCCS(O)(=O)=O)C)[C@@]2(C)[C@@H](O)C1 WBWWGRHZICKQGZ-HZAMXZRMSA-N 0.000 claims description 5
- 244000147568 Laurus nobilis Species 0.000 claims description 4
- 235000017858 Laurus nobilis Nutrition 0.000 claims description 4
- 235000005212 Terminalia tomentosa Nutrition 0.000 claims description 4
- 240000008042 Zea mays Species 0.000 claims description 4
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 4
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 4
- 235000005822 corn Nutrition 0.000 claims description 4
- 230000002421 anti-septic effect Effects 0.000 claims description 3
- RQFQJYYMBWVMQG-IXDPLRRUSA-N chitotriose Chemical compound O[C@@H]1[C@@H](N)[C@H](O)O[C@H](CO)[C@H]1O[C@H]1[C@H](N)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)N)[C@@H](CO)O1 RQFQJYYMBWVMQG-IXDPLRRUSA-N 0.000 claims description 3
- 239000008187 granular material Substances 0.000 claims description 3
- 150000003242 quaternary ammonium salts Chemical class 0.000 claims description 3
- 239000003826 tablet Substances 0.000 claims description 3
- RCEAADKTGXTDOA-UHFFFAOYSA-N OS(O)(=O)=O.CCCCCCCCCCCC[Na] Chemical compound OS(O)(=O)=O.CCCCCCCCCCCC[Na] RCEAADKTGXTDOA-UHFFFAOYSA-N 0.000 claims description 2
- 239000006071 cream Substances 0.000 claims description 2
- 230000008021 deposition Effects 0.000 claims description 2
- 125000005909 ethyl alcohol group Chemical group 0.000 claims description 2
- 238000004062 sedimentation Methods 0.000 claims description 2
- 230000000844 anti-bacterial effect Effects 0.000 claims 1
- 210000000214 mouth Anatomy 0.000 abstract description 16
- 208000004371 toothache Diseases 0.000 abstract description 12
- 241000894006 Bacteria Species 0.000 abstract description 11
- 208000027418 Wounds and injury Diseases 0.000 abstract description 10
- 241000222122 Candida albicans Species 0.000 abstract description 7
- 229940095731 candida albicans Drugs 0.000 abstract description 7
- 241000588724 Escherichia coli Species 0.000 abstract description 6
- 241000191967 Staphylococcus aureus Species 0.000 abstract description 6
- 230000002195 synergetic effect Effects 0.000 abstract description 6
- 206010053692 Wound complication Diseases 0.000 abstract description 4
- 230000035876 healing Effects 0.000 abstract description 4
- 208000024891 symptom Diseases 0.000 abstract description 4
- 239000003242 anti bacterial agent Substances 0.000 abstract description 3
- 230000008520 organization Effects 0.000 abstract description 3
- 238000004140 cleaning Methods 0.000 abstract 1
- 206010025482 malaise Diseases 0.000 abstract 1
- 206010052428 Wound Diseases 0.000 description 9
- 206010006326 Breath odour Diseases 0.000 description 6
- 208000032139 Halitosis Diseases 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 238000012360 testing method Methods 0.000 description 5
- 208000002193 Pain Diseases 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- 230000000996 additive effect Effects 0.000 description 4
- 208000025865 Ulcer Diseases 0.000 description 3
- 230000003385 bacteriostatic effect Effects 0.000 description 3
- 230000001408 fungistatic effect Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000013112 stability test Methods 0.000 description 3
- 230000001629 suppression Effects 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- MKYBYDHXWVHEJW-UHFFFAOYSA-N N-[1-oxo-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propan-2-yl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(C(C)NC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 MKYBYDHXWVHEJW-UHFFFAOYSA-N 0.000 description 2
- 208000025157 Oral disease Diseases 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 229940037003 alum Drugs 0.000 description 2
- 235000019658 bitter taste Nutrition 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 239000003018 immunosuppressive agent Substances 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- 208000030194 mouth disease Diseases 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 241001313857 Bletilla striata Species 0.000 description 1
- 241001478240 Coccus Species 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- 244000004281 Eucalyptus maculata Species 0.000 description 1
- 208000002639 Fissured Tongue Diseases 0.000 description 1
- 239000009636 Huang Qi Substances 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- 241001416180 Moschidae Species 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 235000014676 Phragmites communis Nutrition 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 206010035630 Plicated tongue Diseases 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 206010042682 Swelling face Diseases 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 208000010798 Tongue disease Diseases 0.000 description 1
- 244000290333 Vanilla fragrans Species 0.000 description 1
- 235000009499 Vanilla fragrans Nutrition 0.000 description 1
- 235000012036 Vanilla tahitensis Nutrition 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 239000004411 aluminium Substances 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 230000002457 bidirectional effect Effects 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 229940116229 borneol Drugs 0.000 description 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- RFFOTVCVTJUTAD-UHFFFAOYSA-N cineole Natural products C1CC2(C)CCC1(C(C)C)O2 RFFOTVCVTJUTAD-UHFFFAOYSA-N 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 210000003074 dental pulp Anatomy 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 208000007565 gingivitis Diseases 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000001965 increasing effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 201000001245 periodontitis Diseases 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000011833 salt mixture Substances 0.000 description 1
- 210000001584 soft palate Anatomy 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
- A61K31/125—Camphor; Nuclear substituted derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/722—Chitin, chitosan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/634—Forsythia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01017—Lysozyme (3.2.1.17)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/24—Metalloendopeptidases (3.4.24)
- C12Y304/24075—Lysostaphin (3.4.24.75)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- General Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
本发明提供了一种中药组合物及其制备方法和应用,所述组合物按重量份数包括如下组分:植物提取物1.3‑12份、麝香草酚0.3‑1.5份、薄荷脑0.3‑3份和抑菌剂0.1‑5份。本发明中,植物提取物、麝香草酚、薄荷脑和抑菌剂配方合理,各组分协同增效,促进创伤面愈合,减少局部组织肿胀,缓解创口痛感,清新口气,抑制大肠杆菌、金黄色葡萄球菌和白色念珠菌等口腔有害菌的生长,保持口腔清洁,缓解牙痛等不适症状,具有广阔市场前景。
Description
技术领域
本发明属于中医领域,涉及一种中药组合物及其制备方法和应用,具体涉及一种治疗口腔溃疡、牙龈肿痛和口腔异味的中药组合物及其制备方法和应用。
背景技术
口腔溃疡俗称“口疮”,是一种常见的发生于口腔黏膜的溃疡性损伤病症,多见于口内侧、舌、软腭等部位。口腔溃疡发病原因与多种因素相关,如免疫功能降低、精神紧张、缺乏微量元素、遗传等因素。口腔溃疡发作时疼痛剧烈,局部灼痛明显,严重者会影响饮食、说话,对日常生活造成极大不便;可并发口臭、慢性咽炎等症状。不少人都有过“吃一口,疼一口”的切身感受。
牙痛是指牙齿因各种原因引起的疼痛,牙痛大多是由牙龈炎、牙周炎、龋齿或折裂牙而导致牙髓感染所引起的。中医认为牙痛是由于外感风邪、胃火炽盛、肾虚火旺,虫蚀牙齿等原因所致。为口腔疾患中常见的症状,其表现为:牙龈红肿,遇冷刺激疼痛,面部肿胀等。症状严重者,寝室难安,给工作和生活带来不便。
CN107753952A公开了一种治疗口腔溃疡的药物组合物,各个组份的质量份数之和为100份,由以下组份组成:免疫抑制剂0.5-5份、薄荷醇或薄荷脑0.01-5份、麝香草酚0.01-2份、冰片0.01-6份、桉叶油素0.01-3份、扁竹叶0.1-10份、黄芪0.1-10份、明矾0.01-2份、pH调节剂适量,调解pH至3.0、余量为水。该发明实现了在免疫抑制剂与中药共同配合作用下,对机体免疫系统能起到双向调节的作用,同时兼顾抑制创面细菌生长,能够加快口腔溃疡的创面的愈合,并具有制备简单、成本低的优点,但该组合物含有明矾,直接接触口腔创面容易使铝元素积累,不利于健康,且该组合物pH值为3,刺激创面,患者易产生排斥感。
CN107789535A公开了一种治疗口腔异味的中药制剂,由勒草50-400份、桑白皮50-250份、猪胆汁10-20份、马齿笕50-400份、黄精30-75份、芦根10-50份、白芨20-60份制成。该中药制剂为:胶囊剂、含漱剂、颗粒剂、片剂、丸剂或口服液剂。该发明治疗口臭、口中粘腻、舌火辣感、口苦、口甜、口淡、口酸、舌苔黄厚腻、裂纹舌、口腔溃疡,但该配方中药用量大,成本高,不利于工业化生产。
因此,提供一种成本低,制备方法简单,能高效治疗口腔溃疡、牙龈肿痛和口腔异味的中药组合物,在中医领域具有重要的意义和广阔的市场前景。
发明内容
针对现有技术的不足及实际的需求,本发明提供一种中药组合物及其制备方法和应用,本发明的中药组合物配方合理,各组分协同增效,能有效治疗口腔溃疡、牙龈肿痛和口腔异味,具有广阔的应用前景和市场价值。
为达此目的,本发明采用以下技术方案:
第一方面,本发明提供一种中药组合物,所述组合物按重量份数包括如下组分:
本发明中,植物提取物、麝香草酚、薄荷脑和抑菌剂配方合理,各组分协同增效,麝香草酚与薄荷脑缓解创口痛感,清新口气,抑菌剂能有效抑制口腔有害菌的生长,对大肠杆菌的抑菌率达到99.9%以上,对金黄色葡萄球菌的抑菌率达到80.3%,对白色念珠菌的抑菌率达到99.0%,安全高效,有效缓解牙痛,在本发明所述用量范围内可快速治疗口腔溃疡、牙龈肿痛和口腔异味等口腔问题。
优选地,所述植物提取物的重量份数为1.3-12份,例如可以是1.3份、1.5份、1.8份、2份、2.5份、3份、3.5份、4份、4.5份、5份、5.5份、6份、6.5份、7份、7.5份、8份、8.5份、9份、9.5份、10份、10.5份、11份、11.5份或12份。
优选地,所述麝香草酚的重量份数为0.3-1.5份,例如可以是0.3份、0.4份、0.5份、0.6份、0.7份、0.8份、0.9份、1份、1.1份、1.2份、1.3份、1.4份或1.5份。
优选地,所述薄荷脑的重量份数为0.3-3份,例如可以是0.3份、0.4份、0.5份、0.7份、0.9份、1份、1.1份、1.3份、1.5份、1.6份、1.8份、2份、2.2份、2.5份、2.6份、2.7份、2.8份、2.9份或3份。
优选地,所述抑菌剂的重量份数为0.1-5份,例如可以是0.1份、0.2份、0.3份、0.4份、0.5份、0.7份、0.9份、1份、1.1份、1.3份、1.5份、1.6份、1.8份、2份、2.2份、2.5份、2.6份、2.7份、2.8份、2.9份、3.2份、3.5份、3.8份、4.0份、4.2份、4.5份、4.7份或5份。
优选地,所述组合物还包括胆酸盐。
本发明中,胆酸盐配合植物提取物清热去火,促进创伤面愈合,减少局部组织肿胀,促进其他组分的药效发挥。
优选地,所述胆酸盐的重量份数为0.01-2份,例如可以是0.01份、0.03份、0.05份、0.07份、0.1份、0.3份、0.5份、0.6份、0.7份、0.8份、0.9份、1份、1.1份、1.2份、1.3份、1.4份、1.5份、1.6份、1.7份、1.8份、1.9份或2份。
优选地,所述胆酸盐包括牛胆酸盐、猪胆酸盐或鸡胆酸盐中的任意一种或至少两种的组合,所述组合例如可以是牛胆酸盐和猪胆酸盐的组合,猪胆酸盐和鸡胆酸盐的组合,或牛胆酸盐、猪胆酸盐和鸡胆酸盐的组合。
优选地,所述植物提取物由植物提取得到,所述植物包括连翘、金银花、甘草、玉米须、菊花或粳米中的任意一种或至少两种的组合,所述组合例如可以是连翘和金银花的组合,甘草和玉米须的组合,菊花和粳米的组合,甘草和粳米的组合,甘草和金银花的组合,或金银花、甘草和菊花的组合,优选为甘草和金银花的组合。
优选地,所述甘草和金银花的重量比为(2-5):(1-3),例如可以是2:1、3:2、4:3、5:3、3:1、5:2或2:3。
优选地,所述植物提取物还包括植物精油。
本发明中,植物精油可以提高创面对药物的吸收,同时增加使用舒适感。
优选地,所述植物精油的重量份数为0.3-1.5份,例如可以是0.3份、0.4份、0.5份、0.6份、0.7份、0.8份、0.9份、1份、1.1份、1.2份、1.3份、1.4份或1.5份。
优选地,所述植物精油包括桉叶油、玉树油、樟脑油或月桂叶油中的任一种或至少两种的组合,所述组合例如可以是桉叶油和玉树油的组合,樟脑油和月桂叶油的组合,或桉叶油、玉树油和月桂叶油的组合,优选为桉叶油。
优选地,所述抑菌剂包括水杨酸、乙醇、壳寡糖、聚六亚甲基胍类、溶菌酶、季铵盐类抑菌剂、溶葡萄球菌酶或A.SAP中的任一种或至少两种的组合,例如可以是水杨酸和壳寡糖的组合,乙醇和溶菌酶的组合,季铵盐类抑菌剂和葡萄球菌酶的组合,或聚六亚甲基胍类和A.SAP的组合。
本发明中,抑菌剂与胆酸盐、植物提取物、麝香草酚和薄荷脑协同增效,有效抑制口腔有害菌的生长,有效缓解牙痛。
优选地,所述中药组合物还包括矫味剂3-12份和/或促溶剂3.5-15份。
优选地,所述矫味剂的重量份数为3-12份,例如可以是3份、4份、5份、6份、7份、8份、9份、10份、11份或12份。
优选地,所述促溶剂的重量份数为3.5-15份,例如可以是3.5份、4份、4.5份、5份、6份、7份、8份、9份、10份、11份、12份、13份、14份或15份。
优选地,所述矫味剂包括木糖醇、甜菊素、蔗糖或芳香糖浆中的任一种或至少两种的组合,所述组合例如可以是木糖醇和甜菊素的组合,蔗糖和芳香糖浆的组合,木糖醇和蔗糖的组合,甜菊素和蔗糖的组合,或木糖醇、甜菊素和蔗糖的组合,优选为木糖醇和甜菊素的组合。
优选地,所述木糖醇和甜菊素的重量比为(6-10):(1-4),例如可以是6:1、7:2、8:3、9:4、10:3、7:4或10:4。
本发明发现,在所述矫味剂种类和配比下,可有效改善中药组合物的味道,遮蔽胆酸盐及植物提取物的苦涩味道,提升患者使用依从度,且木糖醇和甜菊素只具有甜味而不增加血糖。
优选地,所述促溶剂包括丙二醇、甘油、吐温或十二烷基硫酸钠中任一种或至少两种的组合,所述组合例如可以是丙二醇和甘油的组合,吐温和十二烷基苯磺酸钠的组合或丙二醇和吐温的组合,优选为丙二醇和甘油的组合。
本发明发现,组合使用丙二醇和甘油,在所述配比下可以促进药物溶解分散,有效成分均匀分布,提高生物利用度。
优选地,所述丙二醇和甘油的重量比为1:(2-6),例如可以是1:2、1:3、1:4、1:5或1:6。
第二方面,本发明提供一种制备如第一方面所述的中药组合物的方法,包括如下步骤:
(1)将植物按重量比混合后加水浸泡,煎煮过滤浓缩,加入溶剂沉淀,过滤,回收溶剂,滤液浓缩得植物提取液备用;
(2)向步骤(1)所得混合液中加入薄荷脑、麝香草酚、植物精油和抗菌剂混合均匀;
(3)向步骤(2)所得混合液中加入矫味剂和促溶剂混合均匀,过滤分装。
优选地,步骤(1)所述煎煮次数为2-3次,例如可以是2次或3次。
优选地,步骤(1)所述煎煮时间为1-2h,例如可以是1h、1.2h、1.4h、1.5h、1.6h、1.8h或2h。
优选地,步骤(1)所述浓缩为浓缩至原混合液的1/3到1/4。
优选地,步骤(1)所述溶剂优选为乙醇。
优选地,步骤(1)所述溶剂用量为加入至溶剂含量60-80%,例如可以是60%、65%、67%、69%、70%、72%、74%、75%、78%、79%或80%。
优选地,步骤(1)所述沉淀时间为5-48h,例如可以是5h、6h、7h、8h、9h、10h、11h、12h、13h、14h、15h、16h、17h、18h、19h、20h、22h、25h、28h、30h、32h、35h、38h、40h、42h、45h或48h。
优选地,步骤(1)之后还包括向所得植物提取液中加入胆酸盐溶液的步骤;
优选地,所述胆酸盐溶液为胆酸盐加水后加热溶解所得,加水量与所述中药组合物的重量比为(30-100):(1-5),例如可以是30:1、35:1、40:1、45:1、50:1、55:1、60:1、65:1、70:1、75:1、80:1、85:1、90:1、95:1或100:1。
优选地,所述方法具体包括如下步骤:
(1)将金银花和甘草按重量比混合后加入10-15倍重量的水中浸泡,煎煮2-3次,每次1-2h,纱布过滤,浓缩至原混合液的1/3到1/4,加入95%乙醇调整至含醇量60-80%,沉淀5-48h,过滤,回收溶剂,滤液浓缩得到植物提取液备用;
(2)向胆酸盐中加水,加水量与中药组合物的重量比(30-100):(1-5),加热溶解,加入步骤(1)所得植物提取液混合均匀;
(3)向步骤(2)所得混合液中加入所述重量份数的薄荷脑、麝香草酚、植物精油和抗菌剂混合均匀;
(4)向步骤(3)所得混合液中加入矫味剂和促溶剂混合均匀,过滤分装。
第三方面,本发明提供一种如第一方面所述的中药组合物用于制备治疗口腔溃疡、牙龈肿痛或口腔异味的药物或制剂中的用途。
优选地,所述制剂包括喷雾剂、含片剂、颗粒剂、乳膏剂或口服液剂。
与现有技术相比,本发明具有如下有益效果:
(1)本发明提供的中药组合物,配方合理,各组分协同增效,麝香草酚与薄荷脑缓解创口痛感,清新口气,在本发明所述用量范围内可快速治疗口腔溃疡、牙龈肿痛和口腔异味等口腔问题;
(2)本发明中通过添加抑菌剂能够有效抑制病菌,对大肠杆菌的抑菌率达到99.9%以上,对金黄色葡萄球菌的抑菌率达到80.3%,对白色念珠菌的抑菌率达到99.0%,矫味剂可提高患者的依从度,市场前景广阔;
(3)本发明提供的中药组合物通过配比少量组分可达显著疗效,经济成本低,制备工艺简单,应用前景广阔。
具体实施方式
为更进一步阐述本发明所采取的技术手段及其效果,以下通过具体实施方式来进一步说明本发明的技术方案,但本发明并非局限在实施例范围内。
实施例1
一种中药组合物,按重量分数包括如下组分:
所述中药组合物的制备方法包括如下步骤:
(1)将甘草和金银花按重量比混合后加500g水浸泡,煎煮2次,每次煎1.5h,过滤浓缩,浓缩至原混合液的1/3,加入乙醇至醇含量60%,沉淀48h,回收溶剂,滤液浓缩得植物提取液备用;
(2)向猪胆酸盐中加1kg水,加热溶解后加入植物提取液混合均匀;
(3)向步骤(2)所得混合液中加入薄荷脑、麝香草酚、A.SAP和桉叶油混合均匀;
(4)向步骤(3)所得混合液中加入木糖醇、甜菊素、丙二醇和甘油,混合均匀,过滤分装,得到所述中药组合物。
实施例2
一种中药组合物,按重量分数包括如下组分:
所述中药组合物的制备方法包括如下步骤:
(1)将金银花和甘草按重量比混合后加600g水浸泡,煎煮3次,每次煎2h,过滤浓缩,浓缩至原混合液的1/4,加入乙醇至醇含量80%,沉淀5h,回收溶剂,滤液浓缩得植物提取液备用;
(2)向牛胆酸盐中加1kg水,加热溶解后加入植物提取液混合均匀;
(3)向步骤(2)所得混合液中加入薄荷脑、麝香草酚、水杨酸和玉树油混合均匀;
(4)向步骤(3)所得混合液中加入甜菊素、蔗糖、吐温和丙二醇,混合均匀,过滤分装,得到所述中药组合物。
实施例3
一种中药组合物,按重量分数包括如下组分:
所述中药组合物的制备方法包括如下步骤:
(1)将连翘和金银花按重量比混合后加300g水浸泡,煎煮3次,每次煎1h,过滤浓缩,浓缩至原混合液的1/3,加入乙醇至醇含量70%,沉淀15h,回收溶剂,滤液浓缩得植物提取液备用;
(2)向鸡胆酸盐中加1kg水,加热溶解后加入植物提取液混合均匀;
(3)向步骤(2)所得混合液中加入薄荷脑、麝香草酚、壳寡糖和樟脑油混合均匀;
(4)向步骤(3)所得混合液中加入木糖醇、甜菊素、丙二醇和甘油,混合均匀,过滤分装,得到所述中药组合物。
实施例4
一种中药组合物,按重量分数包括如下组分:
所述中药组合物的制备方法包括如下步骤:
(1)将甘草和玉米须按重量比混合后加350g水浸泡,煎煮3次,每次煎1.5h,过滤浓缩,浓缩至原混合液的1/4,加入乙醇至醇含量80%,沉淀10h,回收溶剂,滤液浓缩得植物提取液备用;
(2)向猪胆酸盐和鸡胆酸盐混合物中加400g水,加热溶解后加入植物提取液混合均匀;
(3)向步骤(2)所得混合液中加入薄荷脑、麝香草酚、玉树油、溶葡萄球菌酶和月桂叶油混合均匀;
(4)向步骤(3)所得混合液中加入蔗糖、芳香糖浆、丙二醇和甘油,混合均匀,过滤分装,得到所述中药组合物。
实施例5
一种中药组合物,按重量分数包括如下组分:
所述中药组合物的制备方法包括如下步骤:
(1)将菊花和粳米按重量比混合后加600g水浸泡,煎煮2次,每次煎1.5h,过滤浓缩,浓缩至原混合液的1/3,加入乙醇至醇含量65%,沉淀12h,回收溶剂,滤液浓缩得植物提取液备用;
(2)向胆酸盐中加600g水,加热溶解后加入植物提取液混合均匀;
(3)向步骤(2)所得混合液中加入薄荷脑、麝香草酚、桉叶油、水杨酸和樟脑油混合均匀;
(4)向步骤(3)所得混合液中加入甜菊素、蔗糖、丙二醇和甘油,混合均匀,过滤分装,得到所述中药组合物。
实施例6
与实施例1相比,除了不添加胆酸盐之外,其他条件同实施例1。
实施例7
与实施例1相比,除了胆酸盐的添加量为2.5g之外,其他条件同实施例1。
实施例8
与实施例1相比,除了麝香草酚的添加量为2g之外,其他条件同实施例1。
实施例9
与实施例1相比,除了薄荷脑的添加量为3.5g之外,其他条件同实施例1。
实施例10
与实施例1相比,除了植物提取物的添加量为15g之外,其他条件同实施例1。
实施例11
与实施例1相比,除了甘草和金银花的重量比为1:3之外,其他条件同实施例1。
实施例12
与实施例1相比,除了甘草和金银花的重量比为6:1之外,其他条件同实施例1。
实施例13
与实施例1相比,木糖醇和甜菊素的重量比为3:8之外,其他条件同实施例1。
实施例14
与实施例1相比,除了丙二醇和甘油的重量比为2:1之外,其他条件同实施例1。
对比例1
与实施例1相比,除了不添植物提取物之外,其他条件同实施例1。
对比例2
与实施例1相比,除了不添加麝香草酚之外,其他条件同实施例1。
对比例3
与实施例1相比,除了不添加薄荷脑之外,其他条件同实施例1。
对比例4
与实施例1相比,除了不添加抑菌剂之外,其他条件同实施例1。
人群测试
选择190名口腔疾病患者,其中64名口腔溃疡患者,68名口臭患者,58名牙痛患者,分别使用实施例1-14和对比例1-4的中药组合物喷剂,早晚各一次,连续1周后记录效果,采用打分测评的方式,5-效果显著,口腔溃疡愈合,口臭消失,牙痛消失可正常进食,使用舒适无疼痛;3-有效果,口腔溃疡创面减小,口臭减轻,牙痛缓解但不能咀嚼,有轻微刺激感;1-无效果,口腔溃疡无变化,口臭无变化,持续牙痛,刺激性强,创面疼痛。结果见表1。
由表1可知,比较实施例1与实施例7-10可知,胆酸盐、植物提取物、麝香草酚和薄荷脑在本发明所述重量份数范围内效果最佳,过量的组分会影响中药组合物综合效果;比较实施例1与实施例11-14可知,各组分配比对中药组合物的影响,在本发明所述的重量配比下,药效最佳,使用舒适感最佳;比较实施例1与实施例6、对比例1-4可知,各组分协同增效,缺一不可。
抑菌效果及稳定性
抑菌试验:按照实施例1配方制备成喷剂,依据GB15979-2002一次性使用卫生用品卫生标准,附录C4溶出性抗(抑)菌产品抑菌性能试验方法,分别对大肠杆菌、金黄色葡萄球菌和白色念珠菌进行抑菌试验,使用喷剂原液,作用20min,试验重复3次,记录平均值作为结果,结果见表2;
稳定性试验:依据GB15979-2002一次性使用卫生用品卫生标准,附录C4溶出性抗(抑)菌产品抑菌性能试验方法,附录C6稳定性测试方法,分别对大肠杆菌、金黄色葡萄球菌和白色念珠菌进行稳定性试验,将喷剂原液37℃放置90天后,进行抑菌试验,结果见表2。
表2抑菌效果及稳定性
由表2可知,本发明提供的中药组合物抑菌效果显著,稳定性能优越,对大肠杆菌、金黄色葡萄糖球菌和白色念珠菌均有较好的抑菌性,在本发明实施例1所述配比条件下抑菌效果最佳,对大肠杆菌的抑菌率达到99.9%以上,对金黄色葡萄球菌的抑菌率达到80.3%,对白色念珠菌的抑菌率达到99.0%,能有效消除因细菌引起的牙龈肿痛、口腔异味,同时降低口腔溃疡创面细菌感染的风险,保持口腔健康。
综上,本发明提供的中药组合物中,胆酸盐、植物提取物、麝香草酚、薄荷脑和抑菌剂配方合理,各组分协同增效,胆酸盐配合植物提取物可以清热去火,促进创伤面愈合,减少局部组织肿胀,麝香草酚与薄荷脑缓解创口痛感,清新口气,抑菌剂能有效抑制口腔有害菌的生长,安全高效,有效缓解牙痛,在本发明所述用量范围内可快速治疗口腔溃疡、牙龈肿痛和口腔异味等口腔问题。
申请人声明,本发明通过上述实施例来说明本发明的详细方法,但本发明并不局限于上述详细方法,即不意味着本发明必须依赖上述详细方法才能实施。所属技术领域的技术人员应该明了,对本发明的任何改进,对本发明产品各原料的等效替换及辅助成分的添加、具体方式的选择等,均落在本发明的保护范围和公开范围之内。
Claims (10)
1.一种中药组合物,其特征在于,所述组合物按重量份数包括如下组分:
2.根据权利要求1所述的中药组合物,其特征在于,所述组合物还包括胆酸盐;
优选地,所述胆酸盐的重量份数为0.01-2份;
优选地,所述胆酸盐包括牛胆酸盐、猪胆酸盐或鸡胆酸盐中的任意一种或至少两种的组合。
3.根据权利要求1或2所述的中药组合物,其特征在于,所述植物提取物由植物提取得到,所述植物包括连翘、金银花、甘草、玉米须、菊花或粳米中的任意一种或至少两种的组合,优选为甘草和金银花的组合;
优选地,所述甘草和金银花的重量比为(2-5):(1-3);
优选地,所述植物提取物还包括植物精油;
优选地,所述植物精油的重量份数为0.3-1.5份;
优选地,所述植物精油包括桉叶油、玉树油、樟脑油或月桂叶油中的任一种或至少两种的组合,优选为桉叶油。
4.根据权利要求1-3任一项所述的中药组合物,其特征在于,所述抑菌剂包括水杨酸、乙醇、壳寡糖、聚六亚甲基胍类、溶菌酶、季铵盐类抑菌剂、溶葡萄球菌酶或A.SAP中的任一种或至少两种的组合。
5.根据权利要求1-4任一项所述的中药组合物,其特征在于,所述中药组合物还包括矫味剂3-12份和/或促溶剂3.5-15份;
优选地,所述矫味剂包括木糖醇、甜菊素、蔗糖或芳香糖浆中的任一种或至少两种的组合,优选为木糖醇和甜菊素的组合;
优选地,所述木糖醇和甜菊素的重量比为(6-10):(1-4)。
6.根据权利要求1-5中任一项所述的中药组合物,其特征在于,所述促溶剂包括丙二醇、甘油、吐温或十二烷基硫酸钠中任一种或至少两种的组合,优选为丙二醇和甘油的组合;
优选地,所述丙二醇和甘油的重量比为1:(2-6)。
7.一种制备如权利要求1-6任一项所述的中药组合物的方法,其特征在于,包括如下步骤:
(1)将植物按重量比混合后加水浸泡,煎煮过滤浓缩,加入溶剂沉淀,过滤,回收溶剂,滤液浓缩得植物提取液备用;
(2)向步骤(1)所得混合液中加入薄荷脑、麝香草酚、植物精油和抗菌剂混合均匀;
(3)向步骤(2)所得混合液中加入矫味剂和促溶剂混合均匀,过滤分装。
8.根据权利要求7所述的方法,其特征在于,步骤(1)所述水的重量为植物的10-15倍;
优选地,步骤(1)所述煎煮次数为2-3次;
优选地,步骤(1)所述煎煮时间为1-2h;
优选地,步骤(1)所述浓缩为浓缩至原混合液的1/3到1/4;
优选地,步骤(1)所述溶剂优选为乙醇;
优选地,步骤(1)所述溶剂用量为加入至溶剂含量60-80%;
优选地,步骤(1)所述沉淀时间为5-48h;
优选地,步骤(1)之后还包括向所得植物提取液中加入胆酸盐溶液的步骤;
优选地,所述胆酸盐溶液为胆酸盐加水后加热溶解所得,加水量与所述中药组合物的重量比为(30-100):(1-5)。
9.根据权利要求7或8所述的方法,其特征在于,所述方法具体包括如下步骤:
(1)将金银花和甘草按重量比混合后加入10-15倍重量的水中浸泡,煎煮2-3次,每次1-2h,纱布过滤,浓缩至原混合液的1/3到1/4,加入95%乙醇调整至含醇量60-80%,沉淀5-48h,过滤,回收溶剂,滤液浓缩得到植物提取液备用;
(2)向胆酸盐中加水,加水量与中药组合物的重量比(30-100):(1-5),加热溶解,加入步骤(1)所得植物提取液混合均匀;
(3)向步骤(2)所得混合液中加入所述重量份数的薄荷脑、麝香草酚、植物精油和抗菌剂混合均匀;
(4)向步骤(3)所得混合液中加入矫味剂和促溶剂混合均匀,过滤分装。
10.一种如权利要求1-6任一项所述的中药组合物用于制备治疗口腔溃疡、牙龈肿痛或口腔异味的药物或制剂中的用途;
优选地,所述制剂包括喷雾剂、含片剂、颗粒剂、乳膏剂或口服液剂。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810661699.4A CN108685987A (zh) | 2018-06-25 | 2018-06-25 | 一种中药组合物及其制备方法和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810661699.4A CN108685987A (zh) | 2018-06-25 | 2018-06-25 | 一种中药组合物及其制备方法和应用 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108685987A true CN108685987A (zh) | 2018-10-23 |
Family
ID=63849038
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810661699.4A Pending CN108685987A (zh) | 2018-06-25 | 2018-06-25 | 一种中药组合物及其制备方法和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108685987A (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111956664A (zh) * | 2019-12-03 | 2020-11-20 | 云南汉盟制药有限公司 | 一种宠物用组合物及其应用 |
CN112741900A (zh) * | 2021-02-19 | 2021-05-04 | 陕西新研药业有限公司 | 一种复合溶菌酶口腔喷雾剂及其制备方法 |
CN113729034A (zh) * | 2021-07-30 | 2021-12-03 | 阿特美生物科技(海南)有限公司 | 一种二元喷雾植物萃取物的空气消毒剂及其制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101732199A (zh) * | 2008-11-17 | 2010-06-16 | 周绪书 | 一种小儿痱子粉 |
CN105213547A (zh) * | 2015-09-29 | 2016-01-06 | 中山瑞福医疗器械科技有限公司 | 一种口咽护理液及其制备方法 |
CN105380858A (zh) * | 2015-12-04 | 2016-03-09 | 武汉璟泓万方堂医药科技股份有限公司 | 驱蚊抑菌止痒喷剂 |
-
2018
- 2018-06-25 CN CN201810661699.4A patent/CN108685987A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101732199A (zh) * | 2008-11-17 | 2010-06-16 | 周绪书 | 一种小儿痱子粉 |
CN105213547A (zh) * | 2015-09-29 | 2016-01-06 | 中山瑞福医疗器械科技有限公司 | 一种口咽护理液及其制备方法 |
CN105380858A (zh) * | 2015-12-04 | 2016-03-09 | 武汉璟泓万方堂医药科技股份有限公司 | 驱蚊抑菌止痒喷剂 |
Non-Patent Citations (3)
Title |
---|
《全国中草药汇编》编写组: "《全国中草药汇编 上册》", 31 October 1996, 人民卫生出版社 * |
戴慎等: "《中医病证诊疗标准与方剂选用》", 30 November 2001, 人民卫生出版社 * |
武汉璟泓万方堂医药科技股份有限公司: "Q/WFT 028-2018《麝香草酚抑菌喷剂》", 《HTTP://WWW.CPBZ.GOV.CN/STANDARDPRODUCT/TORESULT.DO》 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111956664A (zh) * | 2019-12-03 | 2020-11-20 | 云南汉盟制药有限公司 | 一种宠物用组合物及其应用 |
CN112741900A (zh) * | 2021-02-19 | 2021-05-04 | 陕西新研药业有限公司 | 一种复合溶菌酶口腔喷雾剂及其制备方法 |
CN113729034A (zh) * | 2021-07-30 | 2021-12-03 | 阿特美生物科技(海南)有限公司 | 一种二元喷雾植物萃取物的空气消毒剂及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104887581B (zh) | 一种口腔护理组合物及其制备方法 | |
CN109276475B (zh) | 一种含白及多糖中药牙膏及其制备方法 | |
CN106580866B (zh) | 儿童用牙膏 | |
CN108272862B (zh) | 一种蒲地蓝口腔喷雾剂及其制备方法 | |
CN104382786A (zh) | 一种防脱乌发剂及其制备方法 | |
CN108685987A (zh) | 一种中药组合物及其制备方法和应用 | |
CN111557877B (zh) | 一种含有积雪草提取物的牙膏及其制备方法 | |
US7205009B2 (en) | Composition for treating hair and scalp and method for preparing same | |
CN108938501A (zh) | 应用于口腔护理产品的中药组合物及口腔护理产品 | |
CN108078871B (zh) | 一种含三七稀有皂苷的漱口水及其制备方法 | |
CN109481527A (zh) | 一种制备预防或治疗口腔疾病的中药组合物及其应用 | |
CN101507697B (zh) | 紫珠漱口水 | |
CN104983806A (zh) | 一种治疗口腔疾病的中药组合物、制备方法及其应用 | |
CN110327232B (zh) | 一种救必应漱口水 | |
KR20140020144A (ko) | 한방 화장품조성물 및 그 제조방법 | |
CH714586A2 (de) | Grünteehaltige Mundspülung. | |
CN100486636C (zh) | 治疗牙齿敏感证的糊剂及其制备方法 | |
CN113082195A (zh) | 一种疤痕修复复方精油及其制备方法 | |
CN110403891A (zh) | 一种具有口腔保健作用的中草药牙膏 | |
CN108785348A (zh) | 一种有助于提高初生仔猪存活率的爽身粉 | |
CN1062456C (zh) | 一种治疗粉刺、痤疮的药物的制作方法 | |
CN112933122B (zh) | 一种治疗复发性口腔溃疡的中药外用药物 | |
CN112336678B (zh) | 一种清新口气的牙膏 | |
DE102017004191A1 (de) | Grünteehaltige Mundspülung | |
CN109055061A (zh) | 一种除螨止痒香皂及制备工艺 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20181023 |
|
RJ01 | Rejection of invention patent application after publication |